Infectious Diseases - US measles and pertussis outbreaks expose policy failures, not just vaccine hesitancy
View as a Web Page
News Medical
 
  Infectious Diseases Infectious Diseases logo  
  The latest infectious diseases news from News Medical  
 

[Free eBook] Advancing infectious disease vaccine development[Free eBook] Advancing infectious disease vaccine development

In Infectious disease research, early-phase development is moving fast. To keep up, leading teams are rethinking how they work, from improving sample stabilization and enabling outpatient models to generating high-quality, regulatory-ready data from day one.

Access Your eBook Now
 
   US measles and pertussis outbreaks expose policy failures, not just vaccine hesitancyUS measles and pertussis outbreaks expose policy failures, not just vaccine hesitancy
 
A recent commentary argues that US measles and pertussis outbreaks are not simply the result of vaccine hesitancy but reflect weakened immunization policies, permissive exemptions, and underfunded public health systems. The authors contend that policy environments determine whether pockets of low coverage escalate into large-scale, preventable outbreaks.
 
   New antimicrobial strategies show how science is tackling rising drug resistanceNew antimicrobial strategies show how science is tackling rising drug resistance
 
This narrative review in the British Journal of Biomedical Science examines emerging and recently approved therapeutic strategies to combat antimicrobial resistance, spanning new antibiotics, microbiome interventions, natural products, predatory bacteria, vaccines, and advanced technologies. It highlights both promising innovations and the urgent need for sustained global investment as many approaches remain in early development.
 
 Study quantifies the economic implications of living with HIV
 
Study quantifies the economic implications of living with HIVA recent study, published in Nature Communications, shows that in the Netherlands, people who are diagnosed with HIV are less likely to be employed, work fewer hours, earn less income, and are more likely to receive disability benefits up to seven years after diagnosis.
 
 
 COVID vaccination during pregnancy linked to lower preeclampsia risk
 
COVID vaccination during pregnancy linked to lower preeclampsia riskA new multinational study from the INTERCOVID Consortium, including Ann & Robert H. Lurie Children's Hospital of Chicago, has found that COVID-19 vaccination during pregnancy, particularly when combined with a booster dose, significantly reduces the risk of preeclampsia, a serious and potentially life-threatening pregnancy complication.
 
 
 Study: Booster vaccines reduced severe COVID outcomes
 
Study: Booster vaccines reduced severe COVID outcomesBooster vaccines reduced the risk of COVID‑19–related hospitalisation and death, according to a new study of over 3 million adults who had the autumn 2022 vaccine in England.
 
 
 Study identifies antiviral protein IFN-γ as a potential biomarker for Long COVID fatigue
 
Study identifies antiviral protein IFN-γ as a potential biomarker for Long COVID fatigueSARS-CoV-2 triggers the production of the antiviral protein IFN-γ, which is associated with fatigue, muscle ache and depression.
 
 
 Lingering brain inflammation found after mild COVID infection
 
Lingering brain inflammation found after mild COVID infectionEven a mild case of COVID-19 or the flu can impact the body long after the fever and cough fade, according to new Tulane University research that may help explain why some people struggle to feel fully recovered weeks or months later.
 
 
 Mask-wearing during COVID-19 may have reduced heart attack risk triggered by air pollution
 
Mask-wearing during COVID-19 may have reduced heart attack risk triggered by air pollutionResearchers at Kumamoto University have discovered that behavioral changes during the COVID-19 pandemic-particularly widespread mask-wearing-may have reduced the risk of certain types of heart attacks triggered by air pollution.
 
 
 New daily tablet simplifies long-term HIV care
 
New daily tablet simplifies long-term HIV careA new, daily oral tablet that combines two current HIV treatment medications, bictegravir and lenacapavir (BIC/LEN), may be able to effectively replace more complicated HIV treatment regimens used by people living with HIV who are long-term survivors, according to the results of a new phase 3 clinical trial published in The Lancet.
 
 

How would you rate today's newsletter?

 
             
 
 
Google News Icon Stay updated with the latest in health and medical news! Follow News‑Medical.net on Google News for real‑time updates. Click here to follow us now.
 
Facebook X Instagram LinkedIn Vimeo
Why did you receive this email?
You are receiving this email because you subscribed to updates from AZoNetwork UK Ltd. on one of our websites and requested to be notified of additional information.

Unsubscribe or Update Notification Preferences

Contact | About | Privacy Policy

- - - - - -

Registered Address:
AZoNetwork UK Ltd., NEO, 9 Charlotte St, Manchester, M1 4ET, UK

Manchester | Sydney | Boston

Copyright © 2000-2026